Laboratory frailty index in pancreaticoduodenectomy: short-term safety and long-term prognosis
Surgery Today · 2026-09 · 56 (9) · 2083-2089
DOI: 10.1007/s00595-026-03343-8 ↗Kurz gefasst
Fachartikel in der Zeitschrift Surgery Today, online erschienen am 30.05.2026. Verfasst von Toshiya Abe und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Surgery and Oncology, Graduate School of Medical Sciences, Kyushu University, 3-1-1, Maidashi, Higashi-ku, Fukuoka, 812-8582, Japan. ab…. Hauptthemen laut MEDLINE: Pancreaticoduodenectomy, Frailty, Carcinoma, Pancreatic Ductal, Pancreatic Neoplasms. Die Arbeit nennt 18 Literaturangaben.
Themen: Gerontologische Pflege
Abstract (Originalsprache)
PURPOSE: The Laboratory Frailty Index (FI-lab), derived from routine preoperative laboratory parameters, offers a simple and objective alternative to conventional frailty assessment. However, its clinical relevance in elderly patients undergoing pancreaticoduodenectomy (PD), particularly those with pancreatic ductal adenocarcinoma (PDAC), remains unclear. METHODS: We retrospectively analyzed 350 patients aged ≥ 65 years who underwent PD between 2012 and 2021. Frailty was defined as FI-lab ≥ 0.40. Short-term outcomes, including major postoperative complications (Clavien-Dindo grade ≥IIIa) and in-hospital mortality, were compared between frail and non-frail patients. The long-term outcomes (overall survival [OS] and disease-free survival [DFS]) were evaluated in 166 patients with PDAC. RESULTS: Ninety-seven patients (27.7%) were classified as frail. Frail patients had a lower body mass index, greater intraoperative blood loss, and higher transfusion rates, whereas major complications and mortality rates were comparable between the groups. In patients with PDAC, frailty was associated with shorter OS (27.5 vs. 42.2 months; p = 0.043) and DFS (16.7 vs. 23.4 months; p = 0.046), although it was not an independent prognostic factor. CONCLUSIONS: FI-lab-defined frailty was not associated with perioperative morbidity or mortality after PD. In patients with PDAC, FI-lab may serve as a supplementary tool for preoperative risk stratification by reflecting their physiological vulnerability.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Surgery and Oncology, Graduate School of Medical Sciences, Kyushu University, 3-1-1, Maidashi, Higashi-ku, Fukuoka, 812-8582, Japan. abe.toshiya.011@m.kyushu-u.ac.jp.
- Department of Surgery and Oncology, Graduate School of Medical Sciences, Kyushu University, 3-1-1, Maidashi, Higashi-ku, Fukuoka, 812-8582, Japan.
Zitieren
APA
Abe, T., Nakata, K., Watanabe, Y., Ideno, N., Ikenaga, N., & Nakamura, M. (2026). Laboratory frailty index in pancreaticoduodenectomy: short-term safety and long-term prognosis. Surgery Today, 56(9), 2083-2089. https://doi.org/10.1007/s00595-026-03343-8
Vancouver
Abe T, Nakata K, Watanabe Y, Ideno N, Ikenaga N, Nakamura M. Laboratory frailty index in pancreaticoduodenectomy: short-term safety and long-term prognosis. Surgery Today. 2026;56(9):2083-2089. doi:10.1007/s00595-026-03343-8
BibTeX
@article{Abe2026,
author = {Abe, Toshiya and Nakata, Kohei and Watanabe, Yusuke and Ideno, Noboru and Ikenaga, Naoki and Nakamura, Masafumi},
title = {Laboratory frailty index in pancreaticoduodenectomy: short-term safety and long-term prognosis},
journal = {Surgery Today},
year = {2026},
volume = {56},
number = {9},
pages = {2083--2089},
doi = {10.1007/s00595-026-03343-8}
}
EUVIMED